The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N'-(4-chlorobenzylidene)-2-((3,6-dimethyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)oxy)acetohydrazide ID: ALA5282466
Max Phase: Preclinical
Molecular Formula: C22H19ClN6O2
Molecular Weight: 434.89
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nc(OCC(=O)N/N=C/c2ccc(Cl)cc2)c2c(C)nn(-c3ccccc3)c2n1
Standard InChI: InChI=1S/C22H19ClN6O2/c1-14-20-21(29(28-14)18-6-4-3-5-7-18)25-15(2)26-22(20)31-13-19(30)27-24-12-16-8-10-17(23)11-9-16/h3-12H,13H2,1-2H3,(H,27,30)/b24-12+
Standard InChI Key: AFGAOJIQXSWXHT-WYMPLXKRSA-N
Molfile:
RDKit 2D
31 34 0 0 0 0 0 0 0 0999 V2000
1.1408 0.9086 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8554 1.3209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5674 0.9091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5674 0.0838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8572 -0.3279 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1408 0.0801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3521 -0.1710 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3521 1.1640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8371 0.4963 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8554 2.1462 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1408 2.5587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5657 1.9611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4263 -0.3323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5657 -0.9681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3627 -1.1819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5749 -1.9768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9912 -2.5605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1977 -2.3495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9797 -1.5541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4262 2.1462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2884 2.5587 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4262 1.3209 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0030 2.1462 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7176 2.5587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4323 2.1462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4325 1.3209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1454 0.9102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8602 1.3229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8618 2.1440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1500 2.5605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5749 0.9103 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
3 8 1 0
8 9 2 0
9 7 1 0
2 10 1 0
10 11 1 0
8 12 1 0
6 13 1 0
14 7 1 0
15 14 2 0
16 15 1 0
17 16 2 0
18 17 1 0
14 19 1 0
19 18 2 0
11 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
23 24 2 0
24 25 1 0
26 25 2 0
27 26 1 0
28 27 2 0
29 28 1 0
30 29 2 0
25 30 1 0
28 31 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 434.89Molecular Weight (Monoisotopic): 434.1258AlogP: 3.61#Rotatable Bonds: 6Polar Surface Area: 94.29Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.57CX Basic pKa: 1.99CX LogP: 4.26CX LogD: 4.26Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.37Np Likeness Score: -2.26
References 1. Liu FT, Li NG, Zhang YM, Xie WC, Yang SP, Lu T, Shi ZH.. (2020) Recent advance in the development of novel, selective and potent FGFR inhibitors., 186 [PMID:31761386 ] [10.1016/j.ejmech.2019.111884 ]